Andersson O, Berglund G, Descamps R, Thomis J
Eur J Clin Pharmacol. 1981;21(2):87-92. doi: 10.1007/BF00637506.
28 patients, aged 35-62 years, with uncomplicated hypertension, entered a double-blind, crossover study, in which the effects of single daily doses of sotalol and metoprolol were compared. Both drugs exerted a clinically useful anti-hypertensive effect as monotherapy, or in combination with a thiazide diuretic. No significant difference in hypotensive effects was noted between the two beta-blocking agents, when the dose was titrated to an optimal clinical effect. Treatment with sotalol and metoprolol was associated with a clinically insignificant increase in serum uric acid concentration. The side-effects observed were few, and in only two cases was therapy discontinued. We regard both sotalol and metoprolol as useful anti-hypertensive drugs.
28名年龄在35至62岁之间、患有单纯性高血压的患者参与了一项双盲交叉研究,该研究比较了每日单剂量服用索他洛尔和美托洛尔的效果。两种药物作为单一疗法或与噻嗪类利尿剂联合使用时,均发挥了临床上有效的降压作用。当剂量滴定至最佳临床效果时,两种β受体阻滞剂在降压效果上未观察到显著差异。服用索他洛尔和美托洛尔与血清尿酸浓度临床上无显著升高相关。观察到的副作用较少,仅两例停药。我们认为索他洛尔和美托洛尔都是有用的抗高血压药物。